Latest News

Founded at a pivotal moment in national research policy, Women’s Health Research at Yale helped close critical knowledge gaps in medicine—and is now advancing a new era of biologically-informed care that improves treatment for women and men.

Yale School of Medicine received a $2.5 million gift from the Colton Foundation to advance the work of the Colton Center for Autoimmunity at Yale and the Colton Consortium for Autoimmunity. The consortium is a global partnership among the four Colton Centers at Yale, the University of Pennsylvania (Penn), New York University (NYU), and Tel Aviv University (TAU).

DURHAM, N.C. — The Burroughs Wellcome Fund and The Charles H. Revson Foundation are pleased to announce the recipients of the 2026 Postdoctoral Enrichment Program (PDEP) awards, providing career-development support to postdoctoral researchers from backgrounds historically underrepresented in the biomedical sciences. The Postdoctoral Enrichment Program is designed to help promising postdoctoral fellows to maximize their professional potential by supporting activities that enhance their research careers beyond the scope of traditional training grants.

Nelson LaMarche, PhD, assistant professor of pathology, will receive the V Foundation for Cancer Research 2026 Breaking Barriers in Cancer Research (V Scholar) award. The four-year grant supports faculty who are on track to earn permanent positions early in their cancer research careers by funding laboratory-based fundamental research or translational research.

Markus Müschen, MD, PhD, was selected by the Harrington Discovery Institute as a recipient of its 2026 Scholar-Innovator Award. The scholar awards support breakthrough new treatments for common and rare diseases, including cardiovascular, inflammatory, hematologic, and oncologic disease, using small molecule, biologic, cell-based, and genetic therapies.

Stem cells have reshaped modern biology. At Yale School of Medicine, researchers are uncovering how they function and how to harness them for human health.

Researchers in the Vascular Biology and Therapeutics Program are working to address chronic inflammation, heart disease, and more.

Advances in single-cell, molecular, and genetic techniques drive biomedical innovation, and YSM researchers are expanding what’s possible.

Researchers are uncovering the fundamental rules of immunology. It’s enabling them to better treat disease—and even predict it before it strikes.